Modeling diabetes in minipigs for more accurate testing of potential cell therapies

Since the discovery of human iPS cells, a principal goal for researchers worldwide has been to use them for various medical applications, including cell therapy. Among different human diseases, type 1 diabetes mellitus (T1DM) has been a top priority for cell therapy development.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup